ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag chronic pain genetics genomics immunology ecology

an illustration of a woman holding her head
Could COVID-19 Trigger Chronic Disease in Some People?
Katarina Zimmer | Jul 17, 2020 | 8 min read
A handful of viruses have been associated with long-term, debilitating symptoms in a subset of those who become infected. Early signs hint that SARS-CoV-2 may do the same.
Top 7 in Immunology
Edyta Zielinska | Aug 2, 2011 | 3 min read
A snapshot of the most highly ranked articles in microbiology and related areas, from Faculty of 1000
rheumataology-thumbnail
Underlying Pathways: The Key to Progress in Rheumatology?
Janssen Immunology | Nov 17, 2021 | 4 min read
Understanding immune pathways and disease mechanisms helps address the unmet needs of patients living with difficult-to-treat rheumatic diseases.
Scientific Medicine and Chronic Fatigue Syndrome
Mary Mcnamara | Nov 12, 2000 | 6 min read
Illustration: A. Canamucio There has never been a better time, technologically, for our federal health agencies to launch a significant effort to prevent and control a chronic disease that has inflicted suffering on mankind for centuries. Chronic fatigue syndrome (CFS) is the current name for an illness with many names and a long history. In 1681 Thomas Sydenham, founder of modern clinical, scientific, and public health medicine, described a disease spectrum identical to it called "muscular rheu
10-Year-Old Arthritis Institute Goes Beyond Aches And Pains Of Joints
Karen Young Kreeger | Mar 17, 1996 | 10 min read
And Pains Of Joints (The Scientist, Vol:10, #6, p. 13 & 18, March 18, 1996) SEEKING ADVICE: New NIAMS director Stephen Katz is consulting all sectors of the biomedical community to help set institutional priorities. "Chronic, common, costly, and crippling." That's how Stephen I. Katz, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) since August, describes the diseases that the institute explores. NIAMS is celebrating its 10th anniversary this year
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Scientists Uncovering Mechanisms Of Rheumatoid Arthritis
James Kling | Oct 26, 1997 | 9 min read
Affecting more than 2 million Americans, rheumatoid arthritis (RA) remains an enigma. The chronic swelling and pain brought about by RA can be debilitating in severe cases, and, as is true of most autoimmune diseases, the mechanisms and risk factors that influence onset are poorly understood. But long-suffering patients and eager biotech companies need not give up hope; recent insights into the autoimmune response and a new project that aims to ferret out genetic risks for the disease promise t
Deploying the Body’s Army
Jamie Green and Charlotte Ariyan | Apr 1, 2014 | 10+ min read
Using patients’ own immune systems to fight cancer
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Roll-Your-Own Microarrays
Jim Kling | Jan 6, 2002 | 3 min read
CDNA microarrays hold great promise for characterizing disease and performing genetic studies, but they're not exactly an out-of-the-box technology just yet. Often the scientists must prepare their own chips. Yet, this process is limited by the amount of space on the array itself—forcing researchers to make choices about which genes to include in their sample. Clinical microarray applications are further limited by the availability of sufficient cell numbers for testing purposes. Illumina

Run a Search

ADVERTISEMENT